Jesús
Fortun Abete
Profesor/a Asociado/a en CC. de la Salud
Universitat de Barcelona
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Universitat de Barcelona (53)
2024
-
Additional file 2 of Staphylococcus aureus surgical site infection rates in 5 European countries
figshare
-
Additional file 2 of Staphylococcus aureus surgical site infection rates in 5 European countries
figshare
-
Corrigendum to “Safety and effectiveness of isavuconazole in real-life non-neu tropenic patients” [International Journal of Infectious Diseases 144 (2024) 107070] (International Journal of Infectious Diseases (2024) 144, (S1201971224001413), (10.1016/j.ijid.2024.107070))
International Journal of Infectious Diseases
-
Costs and resource utilization patterns in surgical site infections: a pre-COVID-19 perspective from France, Germany, Spain, and the UK
Journal of Hospital Infection, Vol. 147, pp. 123-132
-
Efficacy and safety of rezafungin and caspofungin in candidaemia and invasive candidiasis: pooled data from two prospective randomised controlled trials
The Lancet Infectious Diseases, Vol. 24, Núm. 3, pp. 319-328
-
Individual and institutional predisposing factors of MRSA surgical site infection and outcomes-a retrospective case-control-study in 14 European high-volume surgical centres
JAC-Antimicrobial Resistance, Vol. 6, Núm. 2
-
Isavuconazole Versus Voriconazole as the First-line Therapy for Solid Organ Transplant Recipients With Invasive Aspergillosis: Comparative Analysis of 2 Multicenter Cohort Studies
Transplantation, Vol. 108, Núm. 11, pp. 2260-2269
-
Management of cytomegalovirus in adult solid organ transplant patients: GESITRA-IC-SEIMC, CIBERINFEC, and SET recommendations update
Transplantation Reviews, Vol. 38, Núm. 4
-
Safety and effectiveness of isavuconazole in real-life non-neutropenic patients
International Journal of Infectious Diseases, Vol. 144
2023
-
Breakthrough invasive fungal infection among patients with haematologic malignancies: A national, prospective, and multicentre study
Journal of Infection, Vol. 87, Núm. 1, pp. 46-53
-
Critical appraisal beyond clinical guidelines for intraabdominal candidiasis
Critical Care, Vol. 27, Núm. 1
-
Efficacy of ceftazidime-avibactam in solid organ transplant recipients with bloodstream infections caused by carbapenemase-producing Klebsiella pneumoniae
American Journal of Transplantation, Vol. 23, Núm. 7, pp. 1022-1034
-
Isavuconazole for the Treatment of Invasive Mold Disease in Solid Organ Transplant Recipients: A Multicenter Study on Efficacy and Safety in Real-life Clinical Practice
Transplantation, Vol. 107, Núm. 3, pp. 762-773
-
Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial
The Lancet, Vol. 401, Núm. 10370, pp. 49-59
-
Staphylococcus aureus surgical site infection rates in 5 European countries
Antimicrobial Resistance and Infection Control, Vol. 12, Núm. 1
2022
-
Erratum: Early Stepdown From Echinocandin to Fluconazole Treatment in Candidemia: A Post Hoc Analysis of Three Cohort Studies (Open Forum Infect Dis (2021) 8:6 DOI: 10.1093/ofid/ofab250)
Open Forum Infectious Diseases
-
Real-Life Use of Ceftolozane/Tazobactam for the Treatment of Bloodstream Infection Due to Pseudomonas aeruginosa in Neutropenic Hematologic Patients: a Matched Control Study (ZENITH Study)
Microbiology Spectrum, Vol. 10, Núm. 3
2021
-
Do high MICs predict the outcome in invasive fusariosis?
The Journal of antimicrobial chemotherapy, Vol. 76, Núm. 4, pp. 1063-1069
-
Early Stepdown from Echinocandin to Fluconazole Treatment in Candidemia: A Post Hoc Analysis of Three Cohort Studies
Open Forum Infectious Diseases, Vol. 8, Núm. 6
-
Impact of the inclusion of an aminoglycoside to the initial empirical antibiotic therapy for gram-negative bloodstream infections in hematological neutropenic patients: a propensity-matched cohort study (AMINOLACTAM study)
Antimicrobial Agents and Chemotherapy, Vol. 65, Núm. 8